Home About Us Contact Us

 

Table of Content - Volume 9 Issue 3 - March 2018


 

Glycosylated hemoglobin levels and complications of acute coronary syndromes - A prospective study at tertiary care hospital

 

Abhijeet A Nashte1*, Ravindra K Shravasti2, Amey S Vaidya3

 

1,3Junior resident, 2Professor, Department of General Medicine Bharati Vidyapeeth Deemed to be University Medical College and Hospital, Sangli, Maharashtra, INDIA.

Email: abhiraj.nashte@gmail.com

 

Abstract              Background and objectives: This study was aimed to find out the role of glycosylated haemoglobin (HbA1c) levels and complications of ACS patient. Methodology: This hospital based prospective observational study was carried out for the period of 15 months from January 2017 to March 2018. A total of 100 patients who presented with ACS were studied. Results: Most of the patients were males (54%) and mean age was 62.36±9.89 years. The mean fasting blood sugar (FBS) levels were 107.64±10.60 mg/dL, post prandial blood sugar (PPBS) levels were 174.62±31.88 mg/dL. HbA1c levels were ≥6.5 percent in majority of the patients (68%) and Complications were noted in 25% of the patients. Left ventricle function (LVF) was noted in 16% and arrhythmia in 5%. Mortality was noted in 2% of the patients. Significantly higher number of patients with HbA1c levels ≥6.5 percent had complications (p=0.048). Conclusion and interpretation: Admission HbA1c levels are associated with in hospital adverse events, complications and outcome in ACS.

Key Word: Acute coronary syndrome; Blood sugar levels; Diabetes mellitus; Glycosylated hemoglobin;

 

INTRODUCTION

Acute coronary syndrome (ACS) is a common emergency faced by physician during career. ACS otherwise known as heart attacks, develops when a coronary artery blockage occurs suddenly. Acute cardiac events that may lead to acute myocardial infarction (AMI) and sudden cardiac death are unpredictable.1 acute coronary syndrome (ACS) is an umbrella term for a wide spectrum of clinical signs and symptoms suggestive of myocardial ischemia and infarction.2everal studies have clearly demonstrated a link between type 2 diabetes and acute coronary syndromes (ACS).3,4 Diabetes is a majorly vascular disease with dual microvascular and macrovascular complications. Macrovascular complications start taking place long before the patient has overt diabetes.5 High prevalence of diabetes and undiagnosed diabetes or prediabetic states are seen in patients with stable or unstable coronary artery disease (CAD).3,7 Several studies have shown prognostic role of hyperglycemia and diabetes in patients with ACS. Hyperglycemia at admission for ACS is associated with less favorable outcome.3,4,8-11 Though acute hyperglycemia may be due to the preexisting diabetes mellitus, it may also occur as a part of stress response to the disease state. Hemoglobin A1c (HbA1c) is less influenced by acute stress. Therefore, HbA1c levels may provide insight into the relation between chronic glucose control and patient outcomes. Thus HbA1c level is an indicator of average blood glucose concentrations over the preceding 2-3 months.12 Moreover, a recent report found that elevated HbA1c levels are also predictive for cardiovascular disease and mortality in patients without DM.13 Hence the present study was undertaken to find out the relation between HbA1c levels and complication of ACS.

 

AIM AND OBJECTIVES

To study Glycosylated hemoglobin levels and complications of acute coronary syndromes – a prospective study at tertiary care hospital

 

MATERIAL AND METHODS

Study design-The study design was a hospital based prospective observational study carried out on a total of 100 patients with ACS were selected for the study at Department of Medicine, Bharati Vidyapeeth Deemed University, Medical College and Hospital, Sangli over period of 15 months. January 2017 to March 2018 after ethical clearance from college and university committee

Inclusion criteria:

  1. All patient admitted to hospital with ACS not having diabetes as past medical history.
  2. criteria to diagnose ACS- a) anginal chest pain, b) typical ECG changes like ST elevation MI, NON ST elevation MI, Unstable Angina and cardiac enzymes in STEMI and NSTEMI - CPKMB and Trop – I
  3. patients above the age of 18 years

Exclusion criteria:

  • Patient not willing to participate in study.
  • Patient having history of past or present diabetes.
  • angina secondary to extra-cardiac causes like anemia, thyroid disease

Investigations

  • fasting Blood sugar levels
  • Post-prandial blood sugar levels.
  • Glycosylated haemoglobin (HbA1c)
  • Cardiac enzymes – CPK MB and Troponin I

Glycosylated haemoglobin: HbA1c was calculated by high performance liquid chromatography(HPLC). Based on ADA 2018 recommended target for HbA1c, a value of ≤6.5 was considered as optimal.82,83

Complications and outcome: Outcome is regarded as the status of the patient at the time of discharge. It may be survival or death of the patient undergoing this study. Complications like arrhythmia, LVF were noted during the course of hospital stay.


 

RESULTS

Table 1: Distribution of patients according to the sex

Sex

Distribution (n=100)

Number

Percentage

Male

54

54.00

Female

46

46.00

Total

100

100.00


Table 2: Distribution of patients according to the age

Age group (Years)

Distribution (n=100)

Number

Percentage

41 to 50

13

13.00

51 to 60

32

32.00

61 to 70

37

37.00

71 to 80

14

14.00

81 to 90

4

4.00

Total

100

100.00

 

 

Table 5: Distribution of patients according to the blood sugar and HbA1c

Blood sugar levels (mg/dL)

Findings

Distribution (n=100)

Number

Percentage

Fasting blood sugar levels (mg/dL)

Normal (<100)

7

7.00

Prediabetes (100 to 125)

82

82.00

Diabetes (≥ 126)

11

11.00

Total

100

100.00

Post prandial blood sugar levels (mg/dL)

Normal (<140)

7

7.00

Above Normal (≥140)

93

93.00

Total

100

100.00

HbA1c levels (%)

< 6.5

32

32.00

≥ 6.5

68

68.00

Total

100

100.00

Table 7: Distribution of patients according to the ECG findings

Findings

Distribution (n=100)

Number

Percentage

STEMI

85

85.00

NSTEMI

14

14.00

Unstable angina

1

1.00

Total

100

100.00

 

Table 10: Distribution of patients according to the complications

Complications

Distribution (n=100)

Number

Percentage

LVF

16

16.00

Arrhythmia

5

5.00

LVF with arrhythmia

4

4.00

Absent

75

75.00

              

Table 11: Association of complications with glycosylated hemoglobin and blood sugar levels

Blood sugar level

Findings

Complications

Total

P value

Absent

Present

 

 

 

No.

%

No.

%

No.

%

 

 

Random

(mg/dL)

< 200

67

76.14

21

23.86

88

88.00

0.347

 

≥200

8

66.67

4

33.33

12

12.00

 

Total

75

75.00

25

25.00

100

100.00

 

Fasting

(mg/dL)

< 100

7

100.00

0

0.00

7

7.00

0.113

 

100 to 125

62

75.61

20

24.39

82

82.00

 

> 126

6

54.55

5

45.45

11

11.00

 

Total

75

75.00

25

25.00

100

100.00

 

Post prandial

(mg/dL)

< 140

6

85.71

1

14.29

7

7.00

0.438

 

≥ 140

69

74.19

24

25.81

93

93.00

 

Total

75

75.00

25

25.00

100

100.00

 

HbA1c (%)

< 6.5

28

87.50

4

12.50

32

32.00

0.048

 

≥ 6.5

47

69.12

21

30.88

68

68.00

 

Total

75

75.00

25

25.00

100

100.00

 

 


DISCUSSION

Nonmodifiable factors that influence risk for coronary artery disease include age and sex. Men have a higher risk than women thus in this study most of the patients were males (54%) and male to female ratio was 1.17:1.14 Most of the patients were (37%) aged between 61 to 70 years and 32% of the patients were aged between 51 to 60 years. The mean age was 62.36±9.89 years. Chest pain has been reported as the cardinal feature in patients with AMI. The WHO requires the presence of chest pain as one of the cornerstone feature for the diagnosis of chest pain15 and All the patients presented with chest pain radiating to left arm /radiating to back (100%). The next common complaint was breathlessness (57%) and vomiting and profuse sweating (45%). Fasting blood sugar levels were between 100 to 125 mg/dL in majority of the patients while ≥126 mg/dL were note in 11% of the patients. The mean fasting blood sugar levels were 107.64±10.60 mg/dL Post prandial blood sugar levels were noted as ≥140 mg/dL in majority of the patients. The mean post prandial blood sugar levels were 174.62±31.88 mg/dL. HbA1c levels were ≥6.5 percent in majority of the patients (68%). The mean HbA1c levels were 6.62±0.73 percent. Based on ECG, majority of the patients were diagnosed with STEMI (85%), followed by NSTEMI (14%). Complications were noted in 25% of the patients. LVF was the common complication noted in 16% of the patients and arrhythmia was noted in 5% of the patients while arrhythmia with LVF was noted in 4% of the patients Majority of the patients (98%) improved and discharged. While mortality was noted in 2% of the patients Significantly higher number of patients with HbA1c levels ≥6.5 percent developed complications (30.88% vs 12.50%; p=0.048) and elevated HbA1c level was a strong and independent predictor of severity and complication in ACS patients even in nondiabetics16

 

CONCLUSION

Overall, the present study showed that, elevated glycated haemoglobin at admission is associated not only with short term complications but also with adverse outcome. These findings require further validation due to the potential limitations of the study outcome. Hence further multicentric studies involving large sample size and long term follow up may provide the predictive role of admission glycated hemoglobin.

 

REFERENCES

  1. Hauffman MD. Coronary heart disease in India. Centre for Chronic Disease Control. Available from: URL: sancd.org/uploads/pdf/factsheet _CHD.pdf Access Date: 18.09.2018
  2. Storrow AB, Gibler WB. Chest pain centers: diagnosis of acute coronary syndromes. Ann Emerg Med 2000; 35: 449-61.
  3. Narayana RH, Kallige NC, Prabhu MV, Chowta MN, Unnikrishnan B. Association between glycosylated hemoglobin and acute coronary syndrome in type 2 diabetes mellitus. Arch Med Health Sci 2015; 3:29-33.
  4. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355:773-8. 
  5. Haffner SM, Stern MP, Hazuda HP etal. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart diseases start ticking before the onset of clinical diabetes. JAMA 1990; 263;2893-8.
  6. Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB, Savage PJ, et al. Trends in all cause and cardiovascular disease mortality among woman and men with and without diabetes mellitus in the Framingham heart Study, 1950 to 2005. Circulation 2009;1728: 119-23.
  7. De Caterina R, Madonna R, Sourij H, Wascher T. Glycaemic control in acute coronary syndromes:prognostic value and therapeutic options. Eur Heart J 2010; 31: 1557-64.
  8. Gasior M, Stasik-Pres G, Pres D, Lech P, Gierlotka M, Lekston A, et al. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kardiol Pol 2007; 65:1031–1038. discussion 1039– 1040.
  9. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001; 79: 207-14.
  10. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL, ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40:1748-54.
  11. Bellodi G, Manicardi V, Malavasi V, Veneri L, Bernini G, Bossini P, Distefano S, Magnanini G, Muratori L, Rossi G, Zuarini A. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989; 64:885-8.
  12. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016; 11:95-104.
  13. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010; 362: 800-11.
  14. Overhaugh KJ. Acute coronary syndrome. Am J Nurs 2009;109(5):42-52
  15. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N, et al. Unrecognised myocardial infarction: epidemiology clinical characteristics and prognostic role of angina pectoris. Ann Intern Med 1995; 122:96-102.
  16. Singh S, Bansal M, Rani K, Gupta V. Prognostic significance of glycosylated hemoglobin in nondiabetic patients in acute coronary syndrome. Heart India 2016;4: 17-22.


 


 


 

 

 



 



 



 






 





 



 



 



 




 

 


 


 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.